However, themajority of Ph+ B-ALL patients often develop resistance to IM via both theBCR::ABL-dependent and BCR-ABL-independent mechanisms [7, 8, 9, 10,11, 12]. Here, BCR is linked to acute lymphoblastic leukemia.